About Intellia (NTLA)
Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide... Read more
- USD20.11
- USD20.98
- USD19.37
- USD47.48
- -20.90%
- 36M
- 1.03M
- 1.21M
- 2.1B
- 19.37
- -42.70%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
